top of page
WHITE PAPERS
Search

Gastric & Pancreatic ONC: A Year In Review
Gastric Cancer Highlights Positive readout shared in February 2023 ESMO plenary showed significant improvement in mPFS and mOS in...


GU Cancers: A Year In Review
RCC Highlights Negative results from the Phase III IMmotion010, CheckMate-914 Part A, and PROSPER trials call into question the benefit...

GYN ONC: A Year In Review
Highlights Long-term follow-up analyses from Phase III SOLO-1 (olaparib maintenance treatment in 1L BRCAm ovarian cancer) and Phase III...

BREAST CANCER: A Year In Review
Highlights Results from monarchE (abemaciclib + ET) confirm the benefit of abemaciclib in in high risk, HR+ BC Although FDA ODAC voted...
bottom of page